November 12, 2012 — Intrinsic Medical Imaging (IMI) introduced its Matrix Volumetric Analytics software for advanced anatomical interrogation at the 2012 annual Transcatheter Cardiovascular Therapeutics (TCT). The technology enables assessment of vascular and heart structure pre- and post-surgery for a wide variety of procedures.
“With the explosion of minimally invasive surgical innovations for both vascular and structural heart disease, a critical need exists for advanced anatomical interrogation, resulting in improved pre-procedure patient selection, accurate device placement and sizing, and post-surgical response to these evolving techniques,” said Evan Appelbaum, M.D., FACC, cardiovascular imaging expert and assistant professor of medicine, Harvard Medical School. “IMI’s Matrix Volumetric Analytics uniquely affords the user seamless fluidity of movement and thorough interrogation of complex anatomy. IMI’s ability to rapidly assess the spatial relationship of devices to adjacent anatomy on the fly should ensure superior diagnostic confidence, improving outcomes for this emerging market’s patient population.”
IMI is the developer of U.S. Food and Drug Administration (FDA)-cleared Matrix Volumetric Analytics software, which provides clinicians with unprecedented advanced visualization, interrogation and quantification of complex anatomical structures data generated by standard computed tomography (CT) scanners. IMI’s patented image-rendering techniques deliver non-compressed, full-fidelity anatomical tools, allowing true virtual x, y, and z-axis visual exploration and quantification in every dimension. Further, while minimizing device artifacts, Matrix Volumetric Analytics allows novel clinical assessment of complex and tortuous anatomical structures, enabling unbridled examination of even the most obscured pre- and post-surgical anatomy.
IMI’s Matrix Volumetric Analytics places the practitioner directly within the complex anatomical structure, creating an ‘on-demand’ virtual bird’s-eye view of all surrounding anatomy. Although the ability to make 2-D measurements will be standard, the unique visual interrogation and appreciation of complex and tortuous anatomy, surgical structures, stents and other implanted devices within complex 3-D vascular and cardiac environments is finally a reality. Aortic dissections, EVAR (endovascular aneurysm repair) and TAVR (transcather aortic valve replacement) procedures, among other structural heart device applications, require precise measurement and visual exploration throughout the entire “X, Y, and Z” imaging planes. IMI’s Matrix Volumetric Analytics provides freedom of movement throughout the human anatomy, allowing a full 360-degree field of volumetric examination by the clinical team responsible for patient outcomes.
“As the evolution of minimally invasive vascular and cardiac surgery accelerates, so must the accompanying critical visualization and quantification tools,” said Jorey Chernett, president and CEO of Intrinsic. “Matrix Volumetric Analytics now delivers this precise comprehensive analytic tool set directly into the clinicians’ hands. True 'Z' axis visual examination and quantification, device blooming suppression, and 3-D anatomic characterization facilitate improved procedural planning, success and ultimately patient outcome.”
Future innovations in areas such as pulmonary medicine for the assessment of COPD and emphysema, orthopedic precision implantation, and oncologic longitudinal tumor density tracking are all natural progressions for IMI’s unique algorithmic applications. “In addition, future application for Intrinsic’s platform will include pulmonary, oncologic and complex orthopedic anatomical procedures,” said Chernett. “We look forward to working with our outstanding clinical partners to evolve this exciting new technology into these and a wide variety of other applications.”
For more information: www.intrinsic-mi.com
February 01, 2024 
